KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dorman Products (DORM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Dorman Products (DORM) over the last 16 years, with Q3 2025 value amounting to $55.5 million.

  • Dorman Products' Cash & Equivalents rose 2299.73% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 2299.73%. This contributed to the annual value of $57.1 million for FY2024, which is 5520.45% up from last year.
  • Dorman Products' Cash & Equivalents amounted to $55.5 million in Q3 2025, which was up 2299.73% from $56.8 million recorded in Q2 2025.
  • Dorman Products' 5-year Cash & Equivalents high stood at $166.6 million for Q1 2021, and its period low was $32.0 million during Q3 2023.
  • In the last 5 years, Dorman Products' Cash & Equivalents had a median value of $52.0 million in 2022 and averaged $58.9 million.
  • Per our database at Business Quant, Dorman Products' Cash & Equivalents plummeted by 6793.15% in 2022 and then skyrocketed by 7602.88% in 2025.
  • Dorman Products' Cash & Equivalents (Quarter) stood at $58.8 million in 2021, then decreased by 21.69% to $46.0 million in 2022, then dropped by 20.03% to $36.8 million in 2023, then soared by 55.2% to $57.1 million in 2024, then fell by 2.86% to $55.5 million in 2025.
  • Its Cash & Equivalents stands at $55.5 million for Q3 2025, versus $56.8 million for Q2 2025 and $60.6 million for Q1 2025.